Cancer Genetics' Hereditary Breast & Ovarian Cancer Panel Selected by Global Biopharma to Power 1,000+ Patient Clinical Study
Bristol-Myers Squibb and Calithera Biosciences Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with CB-839 in Clear Cell Renal Cell Carcinoma
Cancer Genetics, Inc. Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel in Precision Medicine, FOCUS::Lymphoma ™
life science investing AbbVie, Puma Biotechnology, Gilead Sciences and Zogenix Reach Significant Milestones this Month
life science investing Not Your Father's Diagnostics: Ram Selvaraju on How Molecular Genomics Invigorate the Sector
